Entering text into the input field will update the search result below

Exact Sciences Q1 revenue up 87%; shares up 1% after hours

Apr. 26, 2018 4:29 PM ETExact Sciences Corporation (EXAS) StockBy: Douglas W. House, SA News Editor
  • Exact Sciences (NASDAQ:EXAS) Q1 results ($M): Revenue: 90.3 (+86.6%).
  • Net loss: (39.4) (-12.9%); loss/share: (0.33) (-3.1%).
  • Cologuard test volume: 186K (+87%).
  • 2018 Guidance: Revenue: $420M - 430M (unch); Cologuard test volume: 900K - 920K (unch).
  • Q2 Guidance: Cologuard test volume: 220K - 230K.
  • Shares are up 1% after hours on light volume.

Recommended For You

More Trending News

About EXAS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EXAS--
Exact Sciences Corporation